Bath & Body Works, Inc. (NYSE:BBWI) Shares Acquired by Fmr LLC

FMR LLC raised its position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 21.2% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,050,189 shares of the company's stock after purchasing an additional 534,062 shares during the quarter. FMR LLC owned 1.41% of Bath & Body Works worth $118,256,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Fifth Third Wealth Advisors LLC boosted its stake in shares of Bath & Body Works by 4.9% in the fourth quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company's stock worth $271,000 after acquiring an additional 324 shares during the period. SRS Capital Advisors Inc. grew its holdings in Bath & Body Works by 99.7% during the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock valued at $26,000 after buying an additional 329 shares in the last quarter. TD Private Client Wealth LLC raised its position in shares of Bath & Body Works by 24.2% during the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company's stock valued at $54,000 after buying an additional 331 shares during the last quarter. UMB Bank n.a. lifted its holdings in shares of Bath & Body Works by 58.8% in the fourth quarter. UMB Bank n.a. now owns 905 shares of the company's stock worth $35,000 after buying an additional 335 shares in the last quarter. Finally, Lindbrook Capital LLC boosted its position in shares of Bath & Body Works by 81.9% during the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock worth $37,000 after acquiring an additional 431 shares during the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Trading Up 3.4 %

Shares of BBWI traded up $0.92 during mid-day trading on Friday, hitting $28.42. The company's stock had a trading volume of 4,852,461 shares, compared to its average volume of 4,735,779. The firm has a market capitalization of $6.09 billion, a price-to-earnings ratio of 6.93, a PEG ratio of 0.92 and a beta of 1.69. The company's 50-day moving average is $32.15 and its 200-day moving average is $33.84. Bath & Body Works, Inc. has a 52-week low of $24.96 and a 52-week high of $52.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The company reported $2.09 EPS for the quarter, topping the consensus estimate of $2.04 by $0.05. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm had revenue of $2.79 billion during the quarter, compared to analyst estimates of $2.78 billion. As a group, sell-side analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were paid a $0.20 dividend. The ex-dividend date of this dividend was Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 2.81%. Bath & Body Works's dividend payout ratio (DPR) is 21.98%.

Bath & Body Works announced that its Board of Directors has approved a stock repurchase plan on Thursday, February 27th that allows the company to buyback $500.00 million in shares. This buyback authorization allows the company to buy up to 6.4% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's management believes its stock is undervalued.

Analysts Set New Price Targets

BBWI has been the topic of a number of research reports. Raymond James reduced their price objective on Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating on the stock in a research note on Thursday. Robert W. Baird upped their price target on shares of Bath & Body Works from $45.00 to $47.00 and gave the company an "outperform" rating in a research note on Friday, February 28th. Barclays dropped their price objective on shares of Bath & Body Works from $43.00 to $38.00 and set an "equal weight" rating for the company in a research note on Monday, March 3rd. Telsey Advisory Group restated an "outperform" rating and set a $43.00 target price on shares of Bath & Body Works in a research report on Thursday, February 27th. Finally, Argus reiterated a "hold" rating on shares of Bath & Body Works in a research report on Friday, January 10th. Four investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $43.13.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.